CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: polyethylene macromolecule
Accession: CHEBI:53226
browse the term
Definition: A macromolecule composed of ethane or substituted ethane units.
Synonyms: related_synonym: poly(ethene)s; poly(ethylene)s; polyethenes; polyethylene; polyethylenes
G
Crp
C-reactive protein
decreases expression
ISO
Colesevelam Hydrochloride results in decreased expression of CRP protein
CTD
PMID:16616026
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
multiple interactions increases expression
ISO
Colesevelam Hydrochloride promotes the reaction [Simvastatin results in increased expression of HMGCR mRNA] Colesevelam Hydrochloride results in increased expression of HMGCR mRNA
CTD
PMID:22120639
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
G
Ldlr
low density lipoprotein receptor
increases expression
ISO
Colesevelam Hydrochloride results in increased expression of LDLR mRNA
CTD
PMID:22120639
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
G
Acp5
acid phosphatase 5, tartrate resistant
decreases expression
ISO
Polyethylene results in decreased expression of ACP5 mRNA
CTD
PMID:15585240
NCBI chr 8:20,663,984...20,670,604
Ensembl chr 8:20,663,985...20,667,929
G
Ascl1
achaete-scute family bHLH transcription factor 1
decreases expression
ISO
Polyethylene results in decreased expression of ASCL1 mRNA
CTD
PMID:23203475
NCBI chr 7:21,903,136...21,906,003
Ensembl chr 7:21,903,126...21,905,993
G
Bglap
bone gamma-carboxyglutamate protein
decreases expression
ISO
Polyethylene results in decreased expression of BGLAP protein
CTD
PMID:10225790
NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:173,838,518...173,839,495
G
Col1a1
collagen type I alpha 1 chain
decreases expression
ISO
Polyethylene results in decreased expression of COL1A1 mRNA
CTD
PMID:11216681
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
G
Csf2
colony stimulating factor 2
affects secretion
ISO
Polyethylene affects the secretion of CSF2 protein
CTD
PMID:15046894
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
decreases expression
ISO
Polyethylene results in decreased expression of FOS mRNA
CTD
PMID:15585240
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Foxg1
forkhead box G1
decreases expression
ISO
Polyethylene results in decreased expression of FOXG1 mRNA
CTD
PMID:23203475
NCBI chr 6:66,674,797...66,677,611
Ensembl chr 6:66,666,587...66,678,607
G
Hes5
hes family bHLH transcription factor 5
decreases expression
ISO
Polyethylene results in decreased expression of HES5 mRNA
CTD
PMID:23203475
NCBI chr 5:165,522,138...165,523,684
Ensembl chr 5:165,522,234...165,523,001
G
Il1b
interleukin 1 beta
multiple interactions
ISO
Polyethylene analog promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]
CTD
PMID:10602080
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
increases expression multiple interactions
ISO
Polyethylene results in increased expression of IL6 mRNA; Polyethylene results in increased expression of IL6 protein Polyethylene analog inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]
CTD
PMID:10602080 PMID:11771709
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Litaf
lipopolysaccharide-induced TNF factor
increases expression
ISO
Polyethylene results in increased expression of LITAF mRNA
CTD
PMID:17408380
NCBI chr10:4,656,308...4,692,981
Ensembl chr10:4,625,552...4,692,763
G
Neurod1
neuronal differentiation 1
decreases expression
ISO
Polyethylene results in decreased expression of NEUROD1 mRNA
CTD
PMID:23203475
NCBI chr 3:64,359,554...64,363,526
Ensembl chr 3:64,359,395...64,363,649
G
Notch1
notch receptor 1
decreases expression
ISO
Polyethylene results in decreased expression of NOTCH1 mRNA
CTD
PMID:23203475
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
G
Src
SRC proto-oncogene, non-receptor tyrosine kinase
increases expression
ISO
Polyethylene results in increased expression of SRC mRNA
CTD
PMID:15585240
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
G
Tnf
tumor necrosis factor
increases expression multiple interactions affects secretion
ISO
Polyethylene results in increased expression of TNF mRNA Polyethylene analog inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] Polyethylene affects the secretion of TNF protein Etidronic Acid inhibits the reaction [Polyethylene affects the secretion of TNF protein]; ibandronic acid inhibits the reaction [Polyethylene affects the secretion of TNF protein]
CTD
PMID:10413987 PMID:10602080 PMID:17408380
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf11b
TNF receptor superfamily member 11B
decreases expression decreases secretion
ISO
Polyethylene results in decreased expression of TNFRSF11B protein Polyethylene results in decreased secretion of TNFRSF11B protein
CTD
PMID:15046894 PMID:15585240
NCBI chr 7:85,566,520...85,594,526
Ensembl chr 7:85,566,520...85,594,538
G
Tnfsf11
TNF superfamily member 11
affects secretion increases secretion
ISO
Polyethylene affects the secretion of TNFSF11 protein Polyethylene results in increased secretion of TNFSF11 protein
CTD
PMID:15046894 PMID:15585240
NCBI chr15:53,673,850...53,705,325
Ensembl chr15:53,673,877...53,705,445
G
C3
complement C3
increases expression
ISO
styrofoam analog results in increased expression of C3 protein
CTD
PMID:19428933
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
C5
complement C5
increases expression
ISO
styrofoam analog results in increased expression of C5 protein
CTD
PMID:19428933
NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions affects activity
ISO
styrofoam analog promotes the reaction [Cimetidine results in decreased activity of CYP1A2 protein] styrofoam analog affects the activity of CYP1A2 protein
CTD
PMID:19909766
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
decreases activity multiple interactions
ISO
styrofoam analog results in decreased activity of CYP2D6 protein styrofoam analog promotes the reaction [Cimetidine results in decreased activity of CYP2D6 protein]
CTD
PMID:19909766
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
decreases activity multiple interactions
ISO
styrofoam analog results in decreased activity of CYP3A4 protein styrofoam analog promotes the reaction [Cimetidine results in decreased activity of CYP3A4 protein]
CTD
PMID:19909766
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Itgam
integrin subunit alpha M
increases expression
ISO
styrofoam analog results in increased expression of ITGAM protein
CTD
PMID:19428933
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
G
Pf4
platelet factor 4
increases secretion
ISO
styrofoam analog results in increased secretion of PF4 protein
CTD
PMID:19428933
NCBI chr14:17,298,304...17,299,220
Ensembl chr14:17,298,308...17,299,365
G
Ppbp
pro-platelet basic protein
increases secretion
ISO
styrofoam analog results in increased secretion of PPBP protein
CTD
PMID:19428933
NCBI chr14:17,302,326...17,303,130
Ensembl chr14:17,302,326...17,303,130
G
Selp
selectin P
increases expression
ISO
styrofoam results in increased expression of SELP protein
CTD
PMID:21123846
NCBI chr13:76,476,229...76,511,846
Ensembl chr13:76,476,295...76,511,845
G
Angpt1
angiopoietin 1
decreases expression
ISO
Polyvinyl Chloride results in decreased expression of ANGPT1 mRNA
CTD
PMID:12809767
NCBI chr 7:73,528,345...73,783,953
Ensembl chr 7:73,531,486...73,784,067
G
App
amyloid beta precursor protein
multiple interactions
ISO
[Silver Compounds co-treated with Povidone] results in increased expression of APP protein
CTD
PMID:35697184
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
G
Atp5mc2
ATP synthase membrane subunit c locus 2
multiple interactions
EXP
[Silver analog co-treated with Povidone] results in decreased expression of ATP5MC2 mRNA
CTD
PMID:25194297
NCBI chr 7:133,791,341...133,799,713
Ensembl chr 7:133,791,342...133,799,733
G
Bola3
bolA family member 3
multiple interactions
EXP
[Silver analog co-treated with Povidone] results in decreased expression of BOLA3 mRNA
CTD
PMID:25194297
NCBI chr 4:115,853,350...115,862,797
Ensembl chr 4:115,853,350...115,862,797
G
Casp3
caspase 3
multiple interactions
ISO
[Silver co-treated with Povidone] affects the expression of CASP3 protein; [Silver co-treated with Povidone] results in decreased expression of CASP3 mRNA
CTD
PMID:27387714
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
multiple interactions
ISO
[Silver co-treated with Povidone] results in decreased expression of CDKN1A mRNA; [Silver co-treated with Povidone] results in decreased expression of CDKN1A protein
CTD
PMID:27387714
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Col8a1
collagen type VIII alpha 1 chain
multiple interactions
EXP
[Silver analog co-treated with Povidone] results in increased expression of COL8A1 mRNA
CTD
PMID:25194297
NCBI chr11:42,776,851...42,906,432
Ensembl chr11:42,777,628...42,906,424
G
Cox17
cytochrome c oxidase copper chaperone COX17
multiple interactions
EXP
[Silver analog co-treated with Povidone] results in decreased expression of COX17 mRNA
CTD
PMID:25194297
NCBI chr11:62,400,733...62,406,507
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions
EXP
[Silver analog co-treated with Povidone] results in increased expression of CYP1A1 mRNA
CTD
PMID:25194297
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Dad1
defender against cell death 1
multiple interactions
EXP
[Silver analog co-treated with Povidone] results in decreased expression of DAD1 mRNA
CTD
PMID:25194297
NCBI chr15:27,677,286...27,697,120
Ensembl chr15:27,677,268...27,697,347
G
Dlg4
discs large MAGUK scaffold protein 4
multiple interactions
ISO
[Silver Compounds co-treated with Povidone] results in decreased expression of DLG4 protein
CTD
PMID:35697184
NCBI chr10:54,740,700...54,769,097
Ensembl chr10:54,739,470...54,767,153
G
Gbp2
guanylate binding protein 2
multiple interactions
EXP
[Silver analog co-treated with Povidone] results in decreased expression of GBP2 mRNA
CTD
PMID:25194297
NCBI chr 2:231,332,488...231,348,573
Ensembl chr 2:231,332,284...231,348,571
G
H2ax
H2A.X variant histone
multiple interactions
ISO
[Silver co-treated with Povidone] results in increased expression of H2AX protein modified form
CTD
PMID:27387714
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
G
Hmox1
heme oxygenase 1
multiple interactions
EXP
[Silver analog co-treated with Povidone] results in increased expression of HMOX1 mRNA
CTD
PMID:25194297
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Ifit3
interferon-induced protein with tetratricopeptide repeats 3
multiple interactions
EXP
[Silver analog co-treated with Povidone] results in decreased expression of IFIT3 mRNA
CTD
PMID:25194297
NCBI chr 1:232,114,166...232,119,311
Ensembl chr 1:232,114,166...232,119,307
G
Lims1
LIM zinc finger domain containing 1
multiple interactions
EXP
[Silver analog co-treated with Povidone] results in increased expression of LIMS1 mRNA
CTD
PMID:25194297
NCBI chr20:26,309,833...26,418,511
Ensembl chr20:26,309,895...26,418,500
G
Lmnb2
lamin B2
multiple interactions
EXP
[Silver analog co-treated with Povidone] results in decreased expression of LMNB2 mRNA
CTD
PMID:25194297
NCBI chr 7:8,792,628...8,808,665
Ensembl chr 7:8,789,314...8,808,665
G
Map2
microtubule-associated protein 2
multiple interactions
ISO
[Silver Compounds co-treated with Povidone] results in decreased expression of MAP2 protein
CTD
PMID:35697184
NCBI chr 9:67,723,422...67,981,886
Ensembl chr 9:67,723,371...67,979,809
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
ISO
[Silver Compounds co-treated with Povidone] results in increased activity of MAPK1 protein
CTD
PMID:21729742
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
ISO
[Silver Compounds co-treated with Povidone] results in increased activity of MAPK3 protein
CTD
PMID:21729742
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mdm2
MDM2 proto-oncogene
multiple interactions
ISO
[Silver co-treated with Povidone] affects the expression of MDM2 protein; [Silver co-treated with Povidone] results in decreased expression of MDM2 mRNA
CTD
PMID:27387714
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
G
Mt1
metallothionein 1
multiple interactions
EXP
[Silver analog co-treated with Povidone] affects the expression of MT1A mRNA
CTD
PMID:25194297
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049
G
Nfix
nuclear factor I X
multiple interactions
EXP
[Silver analog co-treated with Povidone] results in increased expression of NFIX mRNA
CTD
PMID:25194297
NCBI chr19:23,355,388...23,450,360
Ensembl chr19:23,355,498...23,448,265
G
Nqo1
NAD(P)H quinone dehydrogenase 1
multiple interactions
EXP
[Silver analog co-treated with Povidone] results in increased expression of NQO1 mRNA
CTD
PMID:25194297
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nrm
nurim
multiple interactions
EXP
[Silver analog co-treated with Povidone] results in decreased expression of NRM mRNA
CTD
PMID:25194297
NCBI chr20:2,888,321...2,892,804
Ensembl chr20:2,877,567...2,891,802
G
Nuak2
NUAK family kinase 2
multiple interactions
EXP
[Silver analog co-treated with Povidone] results in decreased expression of NUAK2 mRNA
CTD
PMID:25194297
NCBI chr13:43,753,454...43,770,604
Ensembl chr13:43,753,832...43,770,604
G
Ocln
occludin
affects expression
ISO
Povidone affects the expression of OCLN mRNA
CTD
PMID:19729060
NCBI chr 2:31,657,217...31,707,466
Ensembl chr 2:31,657,220...31,764,150
G
Pink1
PTEN induced kinase 1
multiple interactions
ISO
[Silver Compounds co-treated with Povidone] results in increased expression of PINK1 protein
CTD
PMID:35697184
NCBI chr 5:150,530,523...150,542,635
Ensembl chr 5:150,530,523...150,542,635
G
Ppargc1a
PPARG coactivator 1 alpha
multiple interactions
ISO
[Silver Compounds co-treated with Povidone] results in decreased expression of PPARGC1A protein
CTD
PMID:35697184
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
G
Prkn
parkin RBR E3 ubiquitin protein ligase
multiple interactions
ISO
[Silver Compounds co-treated with Povidone] results in increased expression of PRKN protein
CTD
PMID:35697184
NCBI chr 1:48,688,651...49,882,520
Ensembl chr 1:48,690,556...49,882,555
G
Prpf38b
pre-mRNA processing factor 38B
multiple interactions
EXP
[Silver analog co-treated with Povidone] results in decreased expression of PRPF38B mRNA
CTD
PMID:25194297
NCBI chr 2:196,553,224...196,562,271
Ensembl chr 2:196,553,225...196,562,250
G
Prr13
proline rich 13
multiple interactions
EXP
[Silver analog co-treated with Povidone] results in decreased expression of PRR13 mRNA
CTD
PMID:25194297
NCBI chr 7:133,592,511...133,595,817
Ensembl chr 7:133,592,490...133,601,005
G
Psenen
presenilin enhancer gamma secretase subunit
multiple interactions
EXP
[Silver analog co-treated with Povidone] results in decreased expression of PSENEN mRNA
CTD
PMID:25194297
NCBI chr 1:85,814,905...85,816,654
Ensembl chr 1:85,814,905...85,816,192
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
EXP
[Silver analog co-treated with Povidone] results in increased expression of PTGS2 mRNA
CTD
PMID:25194297
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Ptk2
protein tyrosine kinase 2
multiple interactions
ISO
[Silver Compounds co-treated with Povidone] results in increased activity of PTK2 protein
CTD
PMID:21729742
NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783
G
Rab14
RAB14, member RAS oncogene family
multiple interactions
EXP
[Silver analog co-treated with Povidone] results in increased expression of RAB14 mRNA
CTD
PMID:25194297
NCBI chr 3:18,501,953...18,523,253
Ensembl chr 3:18,501,963...18,523,172
G
Rbm25l1
RNA binding motif protein 25-like 1
multiple interactions
EXP
[Silver analog co-treated with Povidone] results in increased expression of RBM25L1 mRNA
CTD
PMID:25194297
NCBI chr10:10,267,026...10,270,510
Ensembl chr10:10,267,260...10,269,710
G
Samd9l
sterile alpha motif domain containing 9 like
multiple interactions
EXP
[Silver analog co-treated with Povidone] results in decreased expression of SAMD9L mRNA
CTD
PMID:25194297
NCBI chr 4:31,362,054...31,376,412
Ensembl chr 4:31,361,669...31,376,415
G
Selenow
selenoprotein W
multiple interactions
EXP
[Silver analog co-treated with Povidone] results in decreased expression of SELENOW mRNA
CTD
PMID:25194297
NCBI chr 1:76,599,441...76,604,514
Ensembl chr 1:76,598,779...76,604,724 Ensembl chr 1:76,598,779...76,604,724
G
Slc5a3
solute carrier family 5 member 3
multiple interactions
EXP
[Silver analog co-treated with Povidone] results in increased expression of SLC5A3 mRNA
CTD
PMID:25194297
NCBI chr11:31,313,847...31,316,293
Ensembl chr11:31,295,476...31,318,883
G
Sod2
superoxide dismutase 2
multiple interactions
ISO
[Silver co-treated with Povidone] results in increased expression of SOD2 mRNA; [Silver co-treated with Povidone] results in increased expression of SOD2 protein
CTD
PMID:27387714
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Sparc
secreted protein acidic and cysteine rich
multiple interactions
EXP
[Silver analog co-treated with Povidone] results in decreased expression of SPARC mRNA
CTD
PMID:25194297
NCBI chr10:39,516,394...39,538,252
Ensembl chr10:39,516,406...39,538,396
G
Stat2
signal transducer and activator of transcription 2
multiple interactions
EXP
[Silver analog co-treated with Povidone] results in decreased expression of STAT2 mRNA
CTD
PMID:25194297
NCBI chr 7:702,565...718,349
Ensembl chr 7:702,495...718,967
G
Sv2b
synaptic vesicle glycoprotein 2b
multiple interactions
EXP
[Silver analog co-treated with Povidone] results in increased expression of SV2B mRNA
CTD
PMID:25194297
NCBI chr 1:128,978,471...129,152,479
Ensembl chr 1:128,978,473...129,152,479
G
Syp
synaptophysin
multiple interactions
ISO
[Silver Compounds co-treated with Povidone] results in increased expression of SYP protein
CTD
PMID:35697184
NCBI chr X:14,849,444...14,864,553
Ensembl chr X:14,849,444...14,864,745
G
Tiparp
TCDD-inducible poly(ADP-ribose) polymerase
multiple interactions
EXP
[Silver analog co-treated with Povidone] results in increased expression of TIPARP mRNA
CTD
PMID:25194297
NCBI chr 2:149,753,682...149,780,327
Ensembl chr 2:149,753,682...149,780,327
G
Tmtc3
transmembrane O-mannosyltransferase targeting cadherins 3
multiple interactions
EXP
[Silver analog co-treated with Povidone] results in increased expression of TMTC3 mRNA
CTD
PMID:25194297
NCBI chr 7:35,264,886...35,310,010
Ensembl chr 7:35,264,892...35,310,385
G
Tp53
tumor protein p53
multiple interactions
ISO
[Silver co-treated with Povidone] affects the phosphorylation of TP53 protein; [Silver co-treated with Povidone] results in decreased expression of TP53 mRNA; [Silver co-treated with Povidone] results in decreased expression of TP53 protein
CTD
PMID:27387714
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Trappc1
trafficking protein particle complex subunit 1
multiple interactions
EXP
[Silver analog co-treated with Povidone] results in decreased expression of TRAPPC1 mRNA
CTD
PMID:25194297
NCBI chr10:54,045,598...54,047,184
Ensembl chr10:54,045,537...54,047,331
G
Vegfa
vascular endothelial growth factor A
multiple interactions
ISO
[Silver Compounds co-treated with Povidone] results in increased expression of VEGFA protein
CTD
PMID:21729742
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Wdfy1
WD repeat and FYVE domain containing 1
multiple interactions
EXP
[Silver analog co-treated with Povidone] results in increased expression of WDFY1 mRNA
CTD
PMID:25194297
NCBI chr 9:81,034,852...81,092,823
Ensembl chr 9:81,034,849...81,092,775
G
Zfhx3
zinc finger homeobox 3
multiple interactions
EXP
[Silver analog co-treated with Povidone] results in increased expression of ZFHX3 mRNA
CTD
PMID:25194297
NCBI chr19:36,257,196...36,886,104
Ensembl chr19:36,630,254...36,881,771
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all